Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Wellgistics Health Inc ( (WGRX) ) just unveiled an announcement.
Wellgistics Health Inc., a Nasdaq-listed health information technology firm, integrates its EinsteinRx AI platform with its blockchain-enabled PharmacyChain system to optimize prescription drug dispensing for a network of more than 6,500 pharmacies and 200 manufacturers. The company focuses on wholesale distribution, digital prescription routing, direct-to-patient delivery and AI-powered hub services to enhance access and transparency for independent pharmacies in the U.S. prescription drug market.
On March 9, 2026, Wellgistics launched Forzet, a medical food designed for the dietary management of muscle loss associated with weight loss therapies, specifically targeting patients on GLP-1 agonist drugs such as Ozempic, Wegovy and Mounjaro. Initially available through its affiliated pharmacy and selected members of the Wellgistics Pharmacy Network, Forzet is an over-the-counter product classified as a medical food and not an FDA-approved drug, and the company plans to feature it as an adjunct offering within its pharmacy technology and direct-to-consumer channels to capture a share of the rapidly expanding GLP-1 market, where muscle loss is a key limiting side effect.
More about Wellgistics Health Inc
Wellgistics Health Inc., listed on Nasdaq as WGRX, is a health information technology company focused on optimizing the U.S. prescription drug dispensing process. It integrates its EinsteinRx AI-powered pharmacy dispensing optimization platform with its patented blockchain-based PharmacyChain smart contracts system to connect more than 6,500 pharmacies and over 200 manufacturers, providing wholesale distribution, digital prescription routing, direct-to-patient delivery and hub services aimed at independent pharmacies. The company’s end-to-end offerings are designed to improve access, transparency and trust in the prescription drug market, supporting functions such as eligibility checks, adherence support, onboarding, prior authorization and cash-pay fulfillment to streamline patient access to medications.
Average Trading Volume: 800,994
Technical Sentiment Signal: Strong Sell
Current Market Cap: $14.81M
Learn more about WGRX stock on TipRanks’ Stock Analysis page.